Asarina Pharma ApS — Credit Rating and Financial Key Figures

Asarina Pharma ApS (CVR number: 38495712) is a company from KØBENHAVN. The company recorded a gross profit of -884.3 kDKK in 2023. The operating profit was -44.1 mDKK, while net earnings were -42.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was -190.8 %, which can be considered poor and Return on Equity (ROE) was -195.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 49.2 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Asarina Pharma ApS's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.